{"id":13598,"date":"2006-01-30T00:00:00","date_gmt":"2006-01-30T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/uncategorized\/m003fmtg224\/"},"modified":"2019-03-01T15:03:59","modified_gmt":"2019-03-01T15:03:59","slug":"m003fmtg224","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/","title":{"rendered":"3rd Annual Phase IV Clinical Trials"},"content":{"rendered":"<p>  <b>Featured Conference<\/b> <\/p>\n<p>    <b>3rd Annual Phase IV Clinical Trials<\/b><br \/>   January 30 &#8211; February 1, 2006 *  Marriott Atlanta Marquis, GA, USA <\/p>\n<p> <b>Visit the <a href=\"http:\/\/www.marcusevansbb.com\/phaseiv\">conference website<\/a> for more information and to register.<\/b>   <\/p>\n<\/p>\n<p> The value and purpose of a Phase IV clinical study is to increase the knowledge surrounding a new drug, tracking side effects, exploring new uses for the therapy as well as garnering a full understanding of the capability and uses of the drug.  This conference will address the key challenges associated with conducting a phase iv trial and the various methods and opportunities available for addressing these obstacles. <\/p>\n<p> <b>Key Topics<\/b> <\/p>\n<ul type=\"DISC\">\n<li>Strategies in maintaining regulatory compliance in Phase IV clinical trials <\/li>\n<li>Reporting data findings in wide-scale post marketing trials <\/li>\n<li>Federal mandates impacting post marketing research and trials <\/li>\n<li>Strategies in determining new indications for drugs going to market <\/li>\n<li>Overcoming disconnect between scientists and clinical operators <\/li>\n<\/ul>\n<p> <b>Key Speakers<\/b> <\/p>\n<ul type=\"DISC\">\n<li><b>Roy Baranello<\/b>, Assistant VP, Regulatory Policy and Operations, WYETH RESEARCH <\/li>\n<li><b>Jim Kremidas<\/b>, Manager, Global Enrollment Optimization, ELI LILLY  <\/li>\n<li><b>Eleanor S. Segal<\/b>, MD, FAAFP, VP and Head, Global Drug Safety, ACTELION PHARMACEUTICALS <\/li>\n<li><b>Karen Smith MD, PhD, MBA<\/b>, Head, Post Marketing Clinical Trials, USA, BRISTOL-MYERS SQUIBB. <\/li>\n<li><b>David Dworaczyk, PhD<\/b>, Vice President, Clinical Development, KING PHARMACEUTICALS INC.. <\/li>\n<\/ul>\n<p> <a href=\"http:\/\/www.marcusevansbb.com\/phaseiv\">Visit the website for a full panel of speakers<\/a>. <\/p>\n<p> <b>Access Workshops Hosted by:<\/b> <\/p>\n<p> Outcome<br \/> Scirex<br \/> Ovation Research Group <\/p>\n<p> <b>Advisory Board<\/b> <\/p>\n<p> Ron Christensen, CEO, REGISTRAT<br \/> Sean Hart, Group President Late Stage, UBC<br \/> Rich Gliklich, CEO, Outcome<br \/> Raj Tummala, M.D., MBA, Associate Director Neuroscience, Global Medical Affairs, Wyeth Pharmaceuticals<br \/> Joan A. Kroll-Chambers, Director of Strategic Marketing &amp; Development, Tufts Center for the Study of Drug Development, Tufts University <\/p>\n<p> <b>Collaborative Sponsors<\/b><br \/> Dimensional HealthCare<br \/> i3 STATPROBE<br \/> Outcome<br \/> Ovation<br \/> Pace, Parexel<br \/> Pharmanet<br \/> REGISTRAT<br \/> Scirex<br \/> United BioSource Corporation <\/p>\n<p> <b>Exhibit Sponsor<\/b><br \/> Ninaza <\/p>\n<p> Media Partners<br \/> Pharma Marketing News<br \/> PharmaVoice<br \/> Thomson Centerwatch<br \/> Pharma Company Insight<\/p>\n<p> <b>Visit the <a href=\"http:\/\/www.marcusevansbb.com\/phaseiv\">conference website<\/a> for more information and to register.<\/b> <\/p>\n<p> For more information, please contact:<\/p>\n<p><b>Keisha Babb<\/b><br \/> CGI Tower, 3rd Floor<br \/> Warrens<br \/> St. Michael, Barbados<br \/> Tel :1.246.417.5413<br \/> Fax :1.888.844.4901<br \/> EMail : <a href=\"mailto:pharma@marcusevansbb.com\">pharma@marcusevansbb.com<\/a>  <\/p>\n<\/p>\n<p>  <a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/pm-mtgs.html\"><i>Return to list of conferences&#8230;<\/i><\/a> <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Building a well constructed strategic approach to Phase IV studies to meet safety, scientific and regulatory goals with your marketing objectives.<\/p>\n","protected":false},"author":2,"featured_media":13101,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1203],"tags":[],"topic":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>3rd Annual Phase IV Clinical Trials - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"3rd Annual Phase IV Clinical Trials - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"Building a well constructed strategic approach to Phase IV studies to meet safety, scientific and regulatory goals with your marketing objectives.\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2006-01-30T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-03-01T15:03:59+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2019\/03\/pmn-logo-intro-post-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"744\" \/>\n\t<meta property=\"og:image:height\" content=\"419\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/\",\"name\":\"3rd Annual Phase IV Clinical Trials - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2006-01-30T00:00:00+00:00\",\"dateModified\":\"2019-03-01T15:03:59+00:00\",\"author\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"3rd Annual Phase IV Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"3rd Annual Phase IV Clinical Trials - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/","og_locale":"en_US","og_type":"article","og_title":"3rd Annual Phase IV Clinical Trials - Pharma Marketing Network","og_description":"Building a well constructed strategic approach to Phase IV studies to meet safety, scientific and regulatory goals with your marketing objectives.","og_url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/","og_site_name":"Pharma Marketing Network","article_published_time":"2006-01-30T00:00:00+00:00","article_modified_time":"2019-03-01T15:03:59+00:00","og_image":[{"width":744,"height":419,"url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2019\/03\/pmn-logo-intro-post-1.jpg","type":"image\/jpeg"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/","name":"3rd Annual Phase IV Clinical Trials - Pharma Marketing Network","isPartOf":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2006-01-30T00:00:00+00:00","dateModified":"2019-03-01T15:03:59+00:00","author":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m003fmtg224\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"3rd Annual Phase IV Clinical Trials"}]},{"@type":"WebSite","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/13598"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=13598"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/13598\/revisions"}],"predecessor-version":[{"id":13827,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/13598\/revisions\/13827"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/13101"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=13598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=13598"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=13598"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=13598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}